 CARLSBAD, Calif., March 1, 2022 PRNewswire -- Ionis Pharmaceuticals, Inc. Nasdaq: IONS today announced that management will participate in a panel discussion on orphan neurological disease therapeutics at the virtual Cowen 42nd Annual Health Care Conference at 9:10 a.m. 